Characteristics of peripheral blood eosinophils in patients with nocturnal asthma

William Calhoun, M. E. Bates, L. Schrader, J. B. Sedgwick, W. W. Busse

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

A number of mechanisms have been proposed to explain nocturnal exacerbations of asthma including circadian patterns in circulating cortisol and catecholamines. These factors may influence airway smooth muscle tone and circulating eosinophil characteristics and function. Because recent evidence has indicated that eosinophils contribute to airway inflammation and the severity of asthma, we evaluated the relationship among peripheral blood eosinophils, their density distribution, and the appearance of nocturnal asthma. Fifteen patients with asthma were evaluated. Spirometry (FEV1 and FVC) was determined at 0400 and 1600, and the number and density distribution of peripheral blood eosinophils were determined. Five patients had nocturnal asthma, defined as a 15% or greater fall in FEV1 at 0400 versus 1600. The patients with nocturnal asthma had greater numbers of eosinophils (cells x 103/ml) at 0400 (0.845 ± 0.13 versus 0.351 ± 0.03) and 1600 (0.651 ± 0.18 versus 0.319 ± 0.07) and a greater circadian variation with peak eosinophilla at 0400. Furthermore, we found a significant circadian increase in low-density eosinophils (as determined by Percoll density gradient centrifugation) at 0400, but only in patients with nocturnal asthma. These observations suggest that a circadian variation in low density eosinophils may contribute to nocturnal exacerbations of asthma.

Original languageEnglish (US)
Pages (from-to)577-581
Number of pages5
JournalAmerican Review of Respiratory Disease
Volume145
Issue number3
StatePublished - 1992
Externally publishedYes

Fingerprint

Eosinophils
Asthma
Density Gradient Centrifugation
Spirometry
Catecholamines
Smooth Muscle
Hydrocortisone
Cell Count
Inflammation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Calhoun, W., Bates, M. E., Schrader, L., Sedgwick, J. B., & Busse, W. W. (1992). Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. American Review of Respiratory Disease, 145(3), 577-581.

Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. / Calhoun, William; Bates, M. E.; Schrader, L.; Sedgwick, J. B.; Busse, W. W.

In: American Review of Respiratory Disease, Vol. 145, No. 3, 1992, p. 577-581.

Research output: Contribution to journalArticle

Calhoun, W, Bates, ME, Schrader, L, Sedgwick, JB & Busse, WW 1992, 'Characteristics of peripheral blood eosinophils in patients with nocturnal asthma', American Review of Respiratory Disease, vol. 145, no. 3, pp. 577-581.
Calhoun, William ; Bates, M. E. ; Schrader, L. ; Sedgwick, J. B. ; Busse, W. W. / Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. In: American Review of Respiratory Disease. 1992 ; Vol. 145, No. 3. pp. 577-581.
@article{45e10a6f337147c1a829281d28f57542,
title = "Characteristics of peripheral blood eosinophils in patients with nocturnal asthma",
abstract = "A number of mechanisms have been proposed to explain nocturnal exacerbations of asthma including circadian patterns in circulating cortisol and catecholamines. These factors may influence airway smooth muscle tone and circulating eosinophil characteristics and function. Because recent evidence has indicated that eosinophils contribute to airway inflammation and the severity of asthma, we evaluated the relationship among peripheral blood eosinophils, their density distribution, and the appearance of nocturnal asthma. Fifteen patients with asthma were evaluated. Spirometry (FEV1 and FVC) was determined at 0400 and 1600, and the number and density distribution of peripheral blood eosinophils were determined. Five patients had nocturnal asthma, defined as a 15{\%} or greater fall in FEV1 at 0400 versus 1600. The patients with nocturnal asthma had greater numbers of eosinophils (cells x 103/ml) at 0400 (0.845 ± 0.13 versus 0.351 ± 0.03) and 1600 (0.651 ± 0.18 versus 0.319 ± 0.07) and a greater circadian variation with peak eosinophilla at 0400. Furthermore, we found a significant circadian increase in low-density eosinophils (as determined by Percoll density gradient centrifugation) at 0400, but only in patients with nocturnal asthma. These observations suggest that a circadian variation in low density eosinophils may contribute to nocturnal exacerbations of asthma.",
author = "William Calhoun and Bates, {M. E.} and L. Schrader and Sedgwick, {J. B.} and Busse, {W. W.}",
year = "1992",
language = "English (US)",
volume = "145",
pages = "577--581",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Characteristics of peripheral blood eosinophils in patients with nocturnal asthma

AU - Calhoun, William

AU - Bates, M. E.

AU - Schrader, L.

AU - Sedgwick, J. B.

AU - Busse, W. W.

PY - 1992

Y1 - 1992

N2 - A number of mechanisms have been proposed to explain nocturnal exacerbations of asthma including circadian patterns in circulating cortisol and catecholamines. These factors may influence airway smooth muscle tone and circulating eosinophil characteristics and function. Because recent evidence has indicated that eosinophils contribute to airway inflammation and the severity of asthma, we evaluated the relationship among peripheral blood eosinophils, their density distribution, and the appearance of nocturnal asthma. Fifteen patients with asthma were evaluated. Spirometry (FEV1 and FVC) was determined at 0400 and 1600, and the number and density distribution of peripheral blood eosinophils were determined. Five patients had nocturnal asthma, defined as a 15% or greater fall in FEV1 at 0400 versus 1600. The patients with nocturnal asthma had greater numbers of eosinophils (cells x 103/ml) at 0400 (0.845 ± 0.13 versus 0.351 ± 0.03) and 1600 (0.651 ± 0.18 versus 0.319 ± 0.07) and a greater circadian variation with peak eosinophilla at 0400. Furthermore, we found a significant circadian increase in low-density eosinophils (as determined by Percoll density gradient centrifugation) at 0400, but only in patients with nocturnal asthma. These observations suggest that a circadian variation in low density eosinophils may contribute to nocturnal exacerbations of asthma.

AB - A number of mechanisms have been proposed to explain nocturnal exacerbations of asthma including circadian patterns in circulating cortisol and catecholamines. These factors may influence airway smooth muscle tone and circulating eosinophil characteristics and function. Because recent evidence has indicated that eosinophils contribute to airway inflammation and the severity of asthma, we evaluated the relationship among peripheral blood eosinophils, their density distribution, and the appearance of nocturnal asthma. Fifteen patients with asthma were evaluated. Spirometry (FEV1 and FVC) was determined at 0400 and 1600, and the number and density distribution of peripheral blood eosinophils were determined. Five patients had nocturnal asthma, defined as a 15% or greater fall in FEV1 at 0400 versus 1600. The patients with nocturnal asthma had greater numbers of eosinophils (cells x 103/ml) at 0400 (0.845 ± 0.13 versus 0.351 ± 0.03) and 1600 (0.651 ± 0.18 versus 0.319 ± 0.07) and a greater circadian variation with peak eosinophilla at 0400. Furthermore, we found a significant circadian increase in low-density eosinophils (as determined by Percoll density gradient centrifugation) at 0400, but only in patients with nocturnal asthma. These observations suggest that a circadian variation in low density eosinophils may contribute to nocturnal exacerbations of asthma.

UR - http://www.scopus.com/inward/record.url?scp=0026550448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026550448&partnerID=8YFLogxK

M3 - Article

VL - 145

SP - 577

EP - 581

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -